formylmethionyl-leucyl-phenylalanine methyl ester has been researched along with verapamil in 1 studies
Studies (formylmethionyl-leucyl-phenylalanine methyl ester) | Trials (formylmethionyl-leucyl-phenylalanine methyl ester) | Recent Studies (post-2010) (formylmethionyl-leucyl-phenylalanine methyl ester) | Studies (verapamil) | Trials (verapamil) | Recent Studies (post-2010) (verapamil) |
---|---|---|---|---|---|
67 | 1 | 6 | 17,621 | 1,527 | 2,067 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Assaraf, YG; Borgnia, MJ; Eytan, GD | 1 |
1 other study(ies) available for formylmethionyl-leucyl-phenylalanine methyl ester and verapamil
Article | Year |
---|---|
Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity.
Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; CHO Cells; Clone Cells; Computer Simulation; Cricetinae; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Emetine; Gramicidin; Ionophores; Kinetics; Mathematics; Models, Theoretical; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Valinomycin | 1996 |